November 30, 2020.
IPF Partners is pleased to announce the final closing of IPF Fund II, its second Healthcare Growth Debt Fund, at €187.5m, well over the initial €140m fund target. Around 90% of total commitments come from leading European institutional investors, mostly insurance companies and pensions funds.
Since fund launch in 2018, IPF Partners has completed 5 investments, committing €90.5m into small and mid-sized commercial-stage European healthcare companies active in digital health and diagnostic and late development-stage biotechnology companies. The fund targets gross returns of 15% with average investments ranging from €5m to €30m.
Edouard Guillet, a Partner of IPF Partners commented: “We would like to thank all investors for their trust and commitment into IPF Fund II and especially thank our Fund I investors for their continued support. This underlines the demand for a specialised, sector focused private debt fund. We are excited about the growing demand for our type of financing from both private and public companies. In a context of Covid-19 pandemic, Fund II portfolio companies have been mostly unaffected, showing great resilience, alongside the broader healthcare sector.”